Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Nicklin

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Current Opinion in Molecular Therapeutics|September 30, 2003
AAV-based gene transferHildegard Büning, Stuart A Nicklin, Luca Perabo, et al.
Methods in Enzymology|March 9, 2002
Use of phage display to identify novel peptides for targeted gene therapyLorraine M Work, Stuart A Nicklin, Steve J White, et al.
Future Cardiology|December 25, 2012
Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin systemCarolyn Clarke, Monica Flores-Muñoz, Clare A McKinney, et al.
Plos One|October 3, 2012
Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptorMonica Flores-Muñoz, Bruno M D C Godinho, Abdulaziz Almalik, et al.
Clinical Science (London, England : 1979)|March 6, 2014
Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodellingClare A McKinney, Caroline Fattah, Christopher M Loughrey, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2013
Capsid modification strategies for detargeting adenoviral vectorsAlan L Parker, Angela C Bradshaw, Raul Alba, et al.
Human Gene Therapy|March 12, 2015
Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vectorRachel S Dakin, Alan L Parker, Christian Delles, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein graftsSong Wan, Sarah J George, Stuart A Nicklin, et al.
Pharmacology & Therapeutics|July 17, 2012
Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role?Keith E Robertson, Robert A McDonald, Keith G Oldroyd, et al.
The Journal of Gene Medicine|March 18, 2004
In vitro and in vivo characterisation of endothelial cell selective adenoviral vectorsStuart A Nicklin, Steve J White, Campbell G Nicol, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Current Opinion in Molecular Therapeutics|September 30, 2003
AAV-based gene transferHildegard Büning, Stuart A Nicklin, Luca Perabo, et al.
Methods in Enzymology|March 9, 2002
Use of phage display to identify novel peptides for targeted gene therapyLorraine M Work, Stuart A Nicklin, Steve J White, et al.
Future Cardiology|December 25, 2012
Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin systemCarolyn Clarke, Monica Flores-Muñoz, Clare A McKinney, et al.
Plos One|October 3, 2012
Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptorMonica Flores-Muñoz, Bruno M D C Godinho, Abdulaziz Almalik, et al.
Clinical Science (London, England : 1979)|March 6, 2014
Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodellingClare A McKinney, Caroline Fattah, Christopher M Loughrey, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2013
Capsid modification strategies for detargeting adenoviral vectorsAlan L Parker, Angela C Bradshaw, Raul Alba, et al.
Human Gene Therapy|March 12, 2015
Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vectorRachel S Dakin, Alan L Parker, Christian Delles, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein graftsSong Wan, Sarah J George, Stuart A Nicklin, et al.
Pharmacology & Therapeutics|July 17, 2012
Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role?Keith E Robertson, Robert A McDonald, Keith G Oldroyd, et al.
The Journal of Gene Medicine|March 18, 2004
In vitro and in vivo characterisation of endothelial cell selective adenoviral vectorsStuart A Nicklin, Steve J White, Campbell G Nicol, et al.
Pageof 8